XML 66 R48.htm IDEA: XBRL DOCUMENT
v3.25.4

Schedule I: Condensed Financial Information of Registrant (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Condensed Financial Information Disclosure [Abstract] |
Schedule of Condensed Financial Statements |
| Year Ended December 31,
| 2025 |  | 2024 |  | 2023
| (in thousands)
Intercompany revenue | $ | — |  |  | $ | 148 |  |  | $ | 226 |
Selling, general, and administrative expenses | 11,737 |  |  | 13,803 |  |  | 10,812 |
Total operating expenses | 11,737 |  |  | 13,803 |  |  | 10,812 |
Loss from operations | (11,737) |  |  | (13,655) |  |  | (10,586) |
Interest expense, net | 103 |  |  | (387) |  |  | (321) |
Tax receivable agreement liability adjustment | 427 |  |  | (547) |  |  | 100,223 |
Equity in net loss of subsidiaries | (56,153) |  |  | (186) |  |  | (114,697) |
Loss before income taxes | (67,360) |  |  | (14,775) |  |  | (25,381) |
Income tax (benefit) expense | — |  |  | (57) |  |  | 128,698 |
Net loss | $ | (67,360) |  |  | $ | (14,718) |  |  | $ | (154,079) |
| Year Ended December 31,
| 2025 |  | 2024 |  | 2023
| (in thousands)
Net loss | $ | (67,360) |  |  | $ | (14,718) |  |  | $ | (154,079) |
Other comprehensive income (loss): |  |  |  |  |
Foreign currency translation (loss) gain, net of tax effect of $0, $0 and $(770) for the years ended December 31, 2025, 2024 and 2023, respectively | 6,297 |  |  | (1,496) |  |  | 2,423 |
Comprehensive loss attributable to Funko, Inc. | $ | (61,063) |  |  | $ | (16,214) |  |  | $ | (151,656) |
| December 31,
| 2025 |  | 2024
| (in thousands, except per share data)
Assets |  |  |
Current assets: |  |  |
Cash and cash equivalents | $ | 3,486 |  |  | $ | 1,258 |
Income tax receivable | 202 |  |  | 202 |
Total current assets | 3,688 |  |  | 1,460 |
Intercompany receivable | 110,887 |  |  | 113,009 |
Investment in subsidiaries | 71,359 |  |  | 119,097 |
Total assets | $ | 185,934 |  |  | $ | 233,566 |
Liabilities and Stockholders' Equity |  |  |
Current liabilities: |  |  |
Current portion of liabilities under tax receivable agreement | $ | 120 |  |  | $ | 547 |
Total current liabilities | 120 |  |  | 547 |
Commitments and contingencies |  |  |
Stockholders' equity: |  |  |
Class A common stock, par value $0.0001 per share, 200,000 shares authorized; 55,327 shares and 52,967 shares issued and outstanding as of December 31, 2025 and 2024, respectively | 5 |  |  | 5 |
Class B common stock, par value $0.0001 per share, 50,000 shares authorized; 91 shares and 1,430 shares issued and outstanding as of December 31, 2025 and 2024, respectively | — |  |  | — |
Additional paid-in-capital | 357,330 |  |  | 343,472 |
Accumulated other comprehensive income (loss) | 4,621 |  |  | (1,676) |
Accumulated deficit | (176,142) |  |  | (108,782) |
Total stockholders' equity | 185,814 |  |  | 233,019 |
Total liabilities and stockholders' equity | $ | 185,934 |  |  | $ | 233,566 |
| Year Ended December 31,
| 2025 |  | 2024 |  | 2023
| (in thousands)
Operating Activities |  |  |  |  |
Net loss | $ | (67,360) |  |  | $ | (14,718) |  |  | $ | (154,079) |
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: |  |  |  |  |
Equity in net loss of subsidiaries | 56,153 |  |  | 186 |  |  | 114,697 |
Equity-based compensation | 11,536 |  |  | 13,602 |  |  | 10,534 |
Deferred tax (benefit) expense | — |  |  | (57) |  |  | 123,124 |
Tax receivable liability adjustment | (427) |  |  | 547 |  |  | (100,223) |
Changes in operating assets and liabilities, net of amounts acquired: |  |  |  |  |
Income tax receivable | — |  |  | 110 |  |  | 7,219 |
Due from related parties, net | 2,121 |  |  | 5,778 |  |  | 436 |
Accrued expenses and other liabilities | — |  |  | (374) |  |  | 370 |
Net cash provided by operating activities | 2,023 |  |  | 5,074 |  |  | 2,078 |
Investing Activities |  |  |  |  |
Net cash used in investing activities | — |  |  | — |  |  | — |
Financing Activities |  |  |  |  |
Tax receivable agreement payments | — |  |  | (8,960) |  |  | (4) |
Proceeds from exercise of equity-based options | 227 |  |  | 1,410 |  |  | 749 |
Other | (22) |  |  | — |  |  | — |
Net cash provided by (used in) financing activities | 205 |  |  | (7,550) |  |  | 745 |
Net change in cash and cash equivalents | 2,228 |  |  | (2,476) |  |  | 2,823 |
Cash and cash equivalents at beginning of period | 1,258 |  |  | 3,734 |  |  | 911 |
Cash and cash equivalents at end of period | $ | 3,486 |  |  | $ | 1,258 |  |  | $ | 3,734 |
Supplemental Cash Flow Information |  |  |  |  |
Establishment of liabilities under tax receivable agreement | — |  |  | 547 |  |  | — |

X
- References No definition available. + Details
Name: | srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract
Namespace Prefix: | srt_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 04 -Paragraph a -Publisher SEC Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 942 -SubTopic 235 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3 + Details
Name: | srt_ScheduleOfCondensedFinancialStatementsTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration